Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03839459 · OUTCOME

Proportion of Participants With Change in Bone Mineral Density From Screening to 1 Year

Denosumab for Smoldering Multiple Myeloma · Source last updated 2026-06-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
1 year

What was measured

Bone mineral density was assessed using dual energy X ray absorptiometry scans at screening and approximately 1 year after treatment initiation. Participants with evaluable scans within the protocol specified assessment window were included in the analysis.

Analysis population: The analysis includes participants with evaluable bone mineral density assessments at the 1 year time point.

Groups in this outcome

Denosumab

Denosumab: 120mg of Denosumab will be administered subcutaneously once every 4 weeks

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Denosumab13

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Denosumab13Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        13
denoms
  1. counts
    1. group Id
      OG000
      value
      13
    units
    Participants
description
Bone mineral density was assessed using dual energy X ray absorptiometry scans at screening and approximately 1 year after treatment initiation. Participants with evaluable scans within the protocol specified assessment window were included in the analysis.
groups
  1. description
    Denosumab: 120mg of Denosumab will be administered subcutaneously once every 4 weeks
    id
    OG000
    title
    Denosumab
param Type
NUMBER
population Description
The analysis includes participants with evaluable bone mineral density assessments at the 1 year time point.
reporting Status
POSTED
time Frame
1 year
title
Proportion of Participants With Change in Bone Mineral Density From Screening to 1 Year
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice